Leontios Pappas, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholangiocarcinoma | 2 | 2023 | 551 | 0.740 |
Why?
|
| Bile Duct Neoplasms | 2 | 2023 | 603 | 0.740 |
Why?
|
| Orthomyxoviridae | 2 | 2019 | 147 | 0.580 |
Why?
|
| Complementarity Determining Regions | 1 | 2014 | 149 | 0.460 |
Why?
|
| Influenza, Human | 2 | 2019 | 1516 | 0.290 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 2 | 2019 | 158 | 0.260 |
Why?
|
| Bile Ducts, Intrahepatic | 2 | 2023 | 296 | 0.250 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 1931 | 0.240 |
Why?
|
| Biology | 1 | 2023 | 289 | 0.190 |
Why?
|
| Genes, Immunoglobulin | 1 | 2020 | 285 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2018 | 52 | 0.160 |
Why?
|
| Immunoglobulins | 1 | 2020 | 859 | 0.140 |
Why?
|
| Sequence Alignment | 1 | 2020 | 2177 | 0.130 |
Why?
|
| Antibodies, Protozoan | 1 | 2017 | 251 | 0.130 |
Why?
|
| Malaria Vaccines | 1 | 2017 | 164 | 0.130 |
Why?
|
| Plasmodium vivax | 1 | 2017 | 202 | 0.120 |
Why?
|
| Malaria, Vivax | 1 | 2017 | 166 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2018 | 555 | 0.120 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 602 | 0.120 |
Why?
|
| Mutation | 2 | 2018 | 29929 | 0.110 |
Why?
|
| Neoplasms | 1 | 2022 | 21986 | 0.110 |
Why?
|
| Carcinoma | 1 | 2023 | 2330 | 0.100 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2014 | 649 | 0.100 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 759 | 0.100 |
Why?
|
| Protozoan Proteins | 1 | 2017 | 835 | 0.090 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2009 | 55 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 3614 | 0.070 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2009 | 256 | 0.070 |
Why?
|
| Mammary Glands, Human | 1 | 2009 | 203 | 0.070 |
Why?
|
| Antibodies, Viral | 1 | 2019 | 3146 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 3793 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 4872 | 0.070 |
Why?
|
| Software | 1 | 2020 | 4416 | 0.070 |
Why?
|
| Vaccination | 1 | 2017 | 3354 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2014 | 5406 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 4282 | 0.060 |
Why?
|
| Young Adult | 2 | 2023 | 58755 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 13442 | 0.050 |
Why?
|
| Protein Binding | 1 | 2014 | 9312 | 0.050 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2023 | 330 | 0.050 |
Why?
|
| Melanoma | 1 | 2018 | 5689 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2009 | 2823 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 5798 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2014 | 18936 | 0.040 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2018 | 74 | 0.040 |
Why?
|
| Middle Aged | 4 | 2023 | 219192 | 0.040 |
Why?
|
| Switzerland | 1 | 2019 | 323 | 0.040 |
Why?
|
| Heredity | 1 | 2018 | 148 | 0.040 |
Why?
|
| Greece | 1 | 2018 | 336 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2023 | 79984 | 0.040 |
Why?
|
| Serum | 1 | 2019 | 210 | 0.040 |
Why?
|
| Humans | 9 | 2023 | 757566 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2017 | 364 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 468 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 697 | 0.030 |
Why?
|
| Adolescent | 1 | 2023 | 87819 | 0.030 |
Why?
|
| Phylogeny | 1 | 2020 | 2774 | 0.030 |
Why?
|
| Age of Onset | 1 | 2018 | 3296 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2020 | 2532 | 0.020 |
Why?
|
| Pedigree | 1 | 2018 | 4578 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 4710 | 0.020 |
Why?
|
| Proteins | 1 | 2023 | 6024 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2009 | 384 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6204 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2019 | 4540 | 0.020 |
Why?
|
| Female | 4 | 2023 | 389943 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2009 | 507 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 2009 | 488 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9514 | 0.010 |
Why?
|
| Adult | 2 | 2018 | 219725 | 0.010 |
Why?
|
| Risk Factors | 2 | 2023 | 73708 | 0.010 |
Why?
|
| Prognosis | 1 | 2023 | 29488 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2009 | 20992 | 0.010 |
Why?
|
| Phenotype | 1 | 2018 | 16533 | 0.010 |
Why?
|
| Male | 2 | 2018 | 358180 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21217 | 0.010 |
Why?
|
| Algorithms | 1 | 2020 | 13952 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 15774 | 0.010 |
Why?
|
| Cell Survival | 1 | 2009 | 5781 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3664 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 17767 | 0.010 |
Why?
|
| Mice | 2 | 2017 | 81066 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 16881 | 0.010 |
Why?
|
| Animals | 2 | 2017 | 167718 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 167890 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2009 | 23335 | 0.000 |
Why?
|